FTC and NY sue Daraprim maker over access to samples
The Federal Trade Commission and state of New York have alleged that Vyera Pharmaceuticals broke federal antitrust laws by denying access to samples that competitors needed to replicate its infection-treating drug.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10